Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Correction: Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis

Frontiers in aging · 2026 · Dinkla L, Beavers KM, Robbins R et

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 18 20:00 ETSource: Frontiers in aging

From the source

Correction: Bone mineral density and turnover response to GLP-1 receptor agonists in older adults with overweight/obesity and prediabetes/type 2 diabetes: a 20-week pilot trial post hoc analysis

Frontiers in aging · 2026 · Dinkla L, Beavers KM, Robbins R et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →